Literature DB >> 20134203

Neuroimmunomodulation in the pathogenesis of Alzheimer's disease.

Inelia Morales1, Gonzalo Farías, Ricardo B Maccioni.   

Abstract

Evidence has been cumulated on the role of microglia cells deregulation and alterations in their interaction patterns with brain neurons, in the pathway towards neurodegeneration in Alzheimer's disease (AD). After the failure of the amyloid hypothesis to explain AD pathogenesis, current hypotheses focus on tau self-polymerization into pathological oligomers and filaments as a major culprit for neurofibrillary degeneration. It is worth pointing out that formation of tau polymers is consistent with the clinical and neuropathological observations, and that tangles are pathognomonic of AD and related tau disorders. In this context, inflammatory processes play a major role in neuronal degeneration. On the basis of studies on microglia and neuronal cultures, together with experiments in animal models, and the clinical evidence, we postulated that a series of endogenous damage signals activate microglia cells, inducing NFkappa-beta with the consequent release of cytokine mediators such as TNF-alpha, IL-6 and IL-1beta. An overexpression of these mediators may trigger signaling cascades in neurons leading to activation of protein kinases gsk3beta, cdk5, abl kinases, along with inactivation of phosphatases such as PP1, with the resulting hyperphosphorylation and self-aggregation of tau protein into neurotoxic oligomeric species. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20134203     DOI: 10.1159/000258724

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  58 in total

Review 1.  The role of the T cell in age-related inflammation.

Authors:  Richard Macaulay; Arne N Akbar; Sian M Henson
Journal:  Age (Dordr)       Date:  2012-01-15

Review 2.  Effects of neuroinflammation on the regenerative capacity of brain stem cells.

Authors:  Isabella Russo; Sergio Barlati; Francesca Bosetti
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

Review 3.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

4.  Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer's disease.

Authors:  Ai-Guo Xuan; Xue-Bing Pan; Peng Wei; Wei-Dong Ji; Wen-Juan Zhang; Ji-Hong Liu; Le-Peng Hong; Wen-Liang Chen; Da-Hong Long
Journal:  Mol Neurobiol       Date:  2014-05-23       Impact factor: 5.590

Review 5.  The NLRP3 inflammasome in Alzheimer's disease.

Authors:  Meng-Shan Tan; Jin-Tai Yu; Teng Jiang; Xi-Chen Zhu; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-05-19       Impact factor: 5.590

Review 6.  Non-coding RNAs in Alzheimer's disease.

Authors:  Lin Tan; Jin-Tai Yu; Nan Hu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-10-07       Impact factor: 5.590

Review 7.  The role of inflammasome in Alzheimer's disease.

Authors:  Li Liu; Christina Chan
Journal:  Ageing Res Rev       Date:  2014-02-19       Impact factor: 10.895

8.  Spatial regulation of interleukin-6 signaling in response to neurodegenerative stressors in the retina.

Authors:  Stephanie M Sims; Lauren Holmgren; Heather M Cathcart; Rebecca M Sappington
Journal:  Am J Neurodegener Dis       Date:  2012

9.  Cognitive dysfunction with aging and the role of inflammation.

Authors:  Arthur A Simen; Kelly A Bordner; Mark P Martin; Lawrence A Moy; Lisa C Barry
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

10.  Cytokine gene variations associated with subsyndromal depressive symptoms in patients with breast cancer.

Authors:  Shanwell Saad; Laura B Dunn; Theresa Koetters; Anand Dhruva; Dale J Langford; John D Merriman; Claudia West; Steven M Paul; Bruce Cooper; Janine Cataldo; Deborah Hamolsky; Charles Elboim; Bradley E Aouizerat; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2014-04-13       Impact factor: 2.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.